Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z007213 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y013580 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
Symptoms were not reported. No additional AE; Customer called to report TE. PROQUAD was administered to 3 patients on 07/23/2025; This spontaneous report was received from an Administrator and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 23-Jul-2025, the patient was vaccinated with an improperly stored dose of with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Injection (lot #Z007213, expiration date: 05-Oct-2026 or lot #Y013580, expiration date: 03-Feb-2026) 0.5 mL administered for prophylaxis. Suspect vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT), Solution for injection (expiration date, and lot # were not reported). Administered dose of suspect vaccine was exposed to the temperature excursion on an unknown date: 35 Fahrenheit (F) for 72 hours (product storage error, onset date: 23-JUL-2025). Previous temperature excursion was reported as no. Lot # Y013580 was administered to 1 patient and lot # Z007213 was administered to 2 patients. Symptoms were not reported. There was no additional adverse event reported (no adverse event). This is one of three reports received from the same reporter.